Dexamethasone
Yes
No
Dear Healthcare Professional Letters
Cancer Drug and Clinical Indication listed in the MediShield Life Outpatient Cancer Drug List
Standard Drug List
Active ingredient: Dexamethasone
General information
Subsidy Information and Financing Scheme
[SDL] Dexamethasone Tablet 500 mcg, 4 mg
[SDL] Dexamethasone Phosphate Injection 4 mg/mL
[MSHL] Dexamethasone Tablet 0.5 mg, 4 mg
For cancer treatment.
[MSHL] Dexamethasone Injection 4 mg
For cancer treatment.
Drug Guidance for Subsidy
[NR] The Ministry of Health’s Drug Advisory Committee has not recommended listing dexamethasone 0.7 mg intravitreal implant on the MOH List of Subsidised Drugs for treating diabetic macular oedema, macular oedema following retinal vein occlusion and non-infectious uveitis affecting the posterior segment of the eye. The decision was based on the unfavourable clinical and cost-effectiveness of intravitreal dexamethasone implant compared with current treatment options.
Post Marketing Information
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Tablet 500 mcg |
|
Tablet 4 mg |
|
Injection 4 mg/mL |
|
Ophthalmic Ointment 0.1% |
|
Ophthalmic Solution 0.1% |
|
Ophthalmic Solution (Preservative-Free) 0.1% |
|
Ophthalmic Implant 0.7 mg |
|
Submucosal Paste 1 mg/g |
|
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Intravenous / Intramuscular
* Clinical information is available for this product.
Oral
Submucosal
Ophthalmic
* Clinical information is available for this product.
Intravenous / Intramuscular / Intra-articular / Infiltration
* Clinical information is available for this product.
